Sign inCreate account

Report workspace tools

NCT02679287COMPLETEDanonymous

Project Nightlight: Efficacy and System Acceptance of Dinner/Night vs. 24hr Closed Loop Control

Sponsor

Source record

University of Virginia

Phase

Source record

NA

Modality

AI-normalized

medical device

Target

AI-normalized

Type 1 Diabetes Mellitus

Indication / condition

AI-normalized

Diabetes Mellitus, Type 1

Intervention

Source record

CLC

Source & freshness

Source record

NCT ID

NCT02679287

Original source

ClinicalTrials.gov

Source last updated

Jun 09, 2020

Ingested at

May 23, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT02679287

Title

Project Nightlight: Efficacy and System Acceptance of Dinner/Night vs. 24hr Closed Loop Control

Sponsor

University of Virginia

Status

COMPLETED

Phase

NA

Condition raw

Diabetes Mellitus, Type 1

Condition normalized

Diabetes Mellitus, Type 1

Modality raw

Diabetes Mellitus, Type 1

Modality normalized

medical device

Target raw

Type 1 Diabetes Mellitus

Target normalized

Type 1 Diabetes Mellitus

Interventions

CLC

Public preview

Source record

The trial evaluated the efficacy of a Closed-Loop Control (CLC) system for managing blood glucose levels in individuals with Type 1 Diabetes. The study compared different configurations of the CLC system against standard sensor-augmented pump therapy, focusing on user acceptance and clinical outcomes.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Project Nightlight: Efficacy and System Acceptance of Dinner/Night vs. 24hr Closed Loop Control

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT02679287

Status

COMPLETED

Phase

NA

Sponsor

University of Virginia

Executive brief

Investment-Ready Snapshot

The trial evaluated the efficacy of a Closed-Loop Control (CLC) system for managing blood glucose levels in individuals with Type 1 Diabetes. The study compared different configurations of the CLC system against standard sensor-augmented pump therapy, focusing on user acceptance and clinical outcomes.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedJun 09, 2020
Internal syncJun 05, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT02679287

Indication

Diabetes Mellitus, Type 1

Modality

medical device

Target

Type 1 Diabetes Mellitus

Intervention

CLC

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.